
April 2023 Medical News Summary
JAMA Medical News
00:00
The Risks of Simagletide for Weight Loss
The branded version of semagletide known as ozempic has been making headlines because of its ability to aid with weight loss. The drug is actually sold under three brand names, ozempic, rebalcis and we govi. They're all essentially the same drug, but they're sold in different forms with different doses and different indications.
Transcript
Play full episode